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Leucine-rich repeat-containing G protein–coupled receptor
5 (LGR5) is a bona fide marker of adult stem cells in several
epithelial tissues, most notably in the intestinal crypts, and is
highly up-regulated in many colorectal, hepatocellular, and
ovarian cancers. LGR5 activation by R-spondin (RSPO) ligands
potentiatesWnt/-catenin signaling in vitro; however, deletion
of LGR5 in stem cells has little or no effect on Wnt/-catenin
signaling or cell proliferation in vivo. Remarkably, modulation
of LGR5 expression has amajor impact on the actin cytoskeletal
structure and cell adhesion in the absence of RSPO stimulation,
but the molecular mechanism is unclear. Here, we show that
LGR5 interacts with IQ motif-containing GTPase-activating
protein 1 (IQGAP1), an effector of Rac1/CDC42GTPases, in the
regulation of actin cytoskeleton dynamics and cell–cell adhe-
sion. Specifically, LGR5 decreased levels of IQGAP1 phosphor-
ylation at Ser-1441/1443, leading to increased binding of Rac1
to IQGAP1 and thus higher levels of cortical F-actin and
enhanced cell–cell adhesion. LGR5 ablation in colon cancer
cells and crypt stem cells resulted in loss of cortical F-actin,
reduced cell–cell adhesion, and disrupted localization of adhe-
sion-associated proteins. No evidence of LGR5 coupling to any
of the four major subtypes of heterotrimeric G proteins was
found. These findings suggest that LGR5 primarily functions via
the IQGAP1–Rac1 pathway to strengthen cell–cell adhesion in
normal adult crypt stem cells and colon cancer cells.
Leucine-rich repeat-containing G protein–coupled receptor
5 (LGR5)3 has emerged as an authentic marker of adult stem
cells in several epithelial tissues, including the intestine, liver,
skin, stomach, and ovarian epithelium (1, 2). LGR5 and its
closely related homologs LGR4 and LGR6 consist of a large
extracellular domain (ECD) with 17 leucine-rich repeats and a
seven-transmembrane (7TM) domain typical of the rhodopsin
family of G protein–coupled receptors (GPCRs) (3, 4). Several
studies have shown that the four R-spondin (RSPO1–4) growth
factors can bind to LGR4–6 and potentiate canonical/-cate-
nin-dependent Wnt signaling in some cell types (5–7).
Although LGR4–6 are homologous to GPCRs and thus classified
into this family, their function in modulation of Wnt signaling is
independent of heterotrimeric G proteins (5, 6, 8). For LGR4, it
was shown that RSPO–LGR4 potentiatesWnt signaling by inhib-
iting the two E3 ubiquitin ligases RNF43 and ZNRF3, which
otherwise antagonize Wnt signaling through ubiquitination
and subsequent degradation of Wnt receptors (9, 10). More
recently, we showed that RSPO–LGR4 also functions through the
IQGAP1scaffoldingprotein topotentiateWntsignalingvia super-
complex formation with the Wnt receptor complex (11). The
interaction of LGR4 with IQGAP1 enhances levels of -catenin
through MEK1/2-mediated phosphorylation of LRP6 and pro-
motes association with cytoskeletal components to regulate focal
adhesion assembly and cell migration (11).
In contrast, the exact roles and mechanism of LGR5 in the
potentiation of Wnt signaling and the regulation of cellular
functions remain enigmatic. LGR5 is currently the most recog-
nized marker of adult stem cells in multiple epithelial tissues.
Knock-out (KO) of LGR5 in the mouse had no effect on Wnt/
-catenin signaling or the self-renewal of stemcells in the intes-
tine (6, 12, 13) and liver (14), whereas LGR4 is absolutely essen-
tial. Conversely, overexpression or knock-out of LGR5 in
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several colon and liver cancer cell lines led to significant
changes in actin cytoskeleton structures and cell–cell adhesion
in the absence of RSPOstimulation (15, 16). Furthermore, over-
expression of endocytosis-impaired LGR5 led to the formation
of extremely elongated filopodia (also called cytonemes) in
HEK293 cells, suggesting robust, RSPO-independent activity in
cytoskeleton reorganization as HEK293 cells express little
RSPO endogenously (17). Just recently, it was shown that
knock-in of endocytosis-deficient LGR5 into crypt stem cells
resulted in decreased fitness of the stem cells without affecting
proliferation (18). Intriguingly, LGR5 was reported to be con-
stitutively coupled to the G12/13 subclass of heterotrimeric G
proteins in the absence of RSPOs to activate the Rho GTPase
pathway (19).This coupling, however,wasneither verified inde-
pendently nor evaluated in LGR5’s role in the regulation of
actin cytoskeleton. Taken together, these findings suggest that
LGR5 has an important role in stem cell fitness through the
control of the actin cytoskeleton and cell adhesion, although
the exact mechanisms are yet to be defined.
The mammalian IQ motif-containing GTPase-activating
proteins (IQGAPs) are a group of three related intracellular
proteins (IQGAP1–3) with pivotal roles in the regulation of
cytoskeletal structure, cell– cell adhesion, polarization, and
migration (20–22). IQGAPs integrate signaling cross-talk
within the cell through binding to andmodulating the activities
of a plethora of signaling molecules, including members of the
Wnt pathway (APC, -catenin, and E-cadherin), F-actin, mito-
gen-activated protein kinases, and Rho GTPases (20, 22). The
Rho family of small GTPases consists of the Rac, Rho, and
CDC42 subfamilies that are guanine nucleotide-binding pro-
teins that cycle between an active GTP-bound state and an
inactive GDP-bound form to regulate multiple actin dynamics
and signal transduction pathways (23). Although IQGAP1 con-
tains a GTPase-activating protein-like domain, it actually sta-
bilizes GTP binding rather than catalyzes hydrolysis of GTP in
Rac1/CDC42 (20–22). Instead, IQGAP1 binds to the active
forms of Rac1 and CDC42 to coordinate actin assembly and
control cell–cell adhesion (20, 22). Specifically, binding of
Rac1/CDC42 to IQGAP1 inhibits the IQGAP1–-catenin
interaction, leading to an increase in membrane-bound
-catenin, cell–cell adhesion, and F-actin cross-linking (20,
24). Rac1/CDC42 binding to IQGAP1 is inhibited by phosphor-
ylation at two serine sites (Ser-1441 and Ser-1443) of IQGAP1
(25–27). Here, we show that LGR5 interacts with IQGAP1 and
decreases phosphorylation at these two serine sites, leading to
increased binding of Rac1 and consequently enhancement of
cell–cell adhesion. Ablation of LGR5 in colon cancer cells and
in intestinal crypt stem cells results in a disorganized cytoskel-
etal structure with loss of cortical F-actin, suggesting an intri-
cate role for the receptor in cancer and for retaining stem cells
within the intestinal stem cell niche.
Results
Knock-out of LGR5 disrupts the cytoskeletal architecture of
intestinal crypt organoids
LGR5 expression is restricted to the crypt stem cells in the
intestine, but its conditional knock-out was found to have no
obvious effect on the proliferation and differentiation of the
stemcells both in vivo and ex vivo (6, 28).We askedwhether loss
of LGR5 affects cytoskeletal structures of crypt stem cells given
the effect of LGR5 on the actin cytoskeleton in cancer cell lines
(15, 16). Intestinal organoids were generated from LGR5/
(LGR5-EGFP-IRES-creERT2) homozygotes and their wild-
type (WT) littermates and cultured in Matrigel as described
(29). LGR5 KO was verified by genotyping and positive GFP
expression in the stem cells (Fig. 1A). The organoids were pas-
saged two to three times, and no obvious difference was
observed between organoids of LGR5/ and those of WT in
growth and morphology. F-actin staining with rhodamine-
phalloidin showed that LGR5/ organoids had significantly
lower levels of cortical F-actin, particularly on the basolateral
side of the crypts (Fig. 1, B and C). Additionally, -catenin was
disorganized in LGR5/ organoids (Fig. 1, D and E). In WT
organoids, -catenin was clearly localized to the cytoplasmic
membrane, especially at the cell–cell junctions, with some
cytoplasmic expression (Fig. 1D). Quantification of the staining
indicated that only 11% of cells in LGR5/ crypts retained
wild-type levels of -catenin at the cell–cell junction (p 
0.001) (Fig. 1E). These results suggest that LGR5 is critical for
the organization of actin cytoskeletal structures in crypt stem
cells and potentially cell–cell adhesion, but the exact mecha-
nisms involved remain unknown.
Overexpression of LGR5 alters actin cytoskeleton and
increases cell–cell adhesion
To understand how LGR5 regulates actin cytoskeleton and
cell adhesion, we examined the effect of overexpressing LGR5
in epithelial cell lines. CHO cells stably overexpressing full-
length human LGR5 were obtained, and receptor expression
was analyzed using LGR5-specific antibody. Immunocyto-
chemistry (ICC) analysis showed that LGR5 was located on the
cell surface (Fig. 2A, panels a and b). Interestingly, it was appar-
ent that cells overexpressing LGR5 were slightly more rounded
and substantially reduced in size, and they appeared more
adherent and compact (Fig. 2A, panels c and d). These observa-
tions paralleled the morphological changes observed in cancer
cell lines following LGR5 overexpression (15, 16). Quantifica-
tion of relative cell length showed that CHO-LGR5 cells were
shorter when compared with parental CHO cells (Fig. 2B).
Phalloidin staining showed an apparent increase in cortical
F-actin in CHO-LGR5 cells when compared with parental cells
(Fig. 2A, panels e and f). Quantification of the average cortical
actin fluorescence intensity per cell indicated a significant
increase in intensity in CHO-LGR5 cells (p  0.001) (Fig. 2C).
We then asked whether these LGR5-induced changes involve
RSPO ligands. RT-PCR analysis showed that parental and
CHO-LGR5 cell lines did not express any of the four RSPOs
(supplemental Fig. S1), indicating that LGR5 has constitutive or
RSPO-independent activity in regulating the actin cytoskeleton
and cell morphology.
Given the changes induced by LGR5 in the actin cytoskele-
ton, the effects of LGR5 on cell migration and adhesion were
also determined. CHO-LGR5 cells showed a significant reduc-
tion in cell migration using the wound healing assay (Fig. 2D).
In the calcein-AM-based cell–cell adhesion assay, which mea-
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sures the retention of a fluorescent dye in cells attached to other
cells without the dye (30), CHO-LGR5 cells exhibited signifi-
cantly stronger adhesion compared with parental CHO cells
(Fig. 2E).
Previously, we reported the generation and characterization
of HEK293T cells stably expressing vector, LGR5-WT, and
LGR5-C (endocytosis-impaired due to the deletion of the
C-terminal tail sequence AA 837–907) in the regulation of
Wnt/-catenin signaling (31). Our findings showed that the
C-terminal tail of LGR5 is not only important for internaliza-
tion but also critical for regulating receptor signaling. Snyder et
al. (32) reported that overexpression of an endocytosis-im-
paired LGR5 mutant with a truncated C-terminal tail led to
formation of cytonemes in HEK293 cells, whereas LGR5-WT
displayed few or no such cellular protrusions. Furthermore, the
same LGR5 mutant was recently shown to reduce stem cell
fitness in vivo by lineage tracing (18). Here, we examined the
effect ofMyc-tagged LGR5-WTand -Coverexpression on the
Figure 1. Loss of LGR5 in intestinal crypt organoids resulted in disorganization of F-actin and -catenin. A, bright-field micrographs of wild-type and
LGR5KOmouse intestinal crypt organoids cultured inMatrigel. B, confocalmicroscopy images of F-actin (red) inwild-type and LGR5KOorganoids. Nucleiwere
counterstained using TO-PRO-3 (blue). C, quantification of cortical F-actin. D, confocal images of -catenin in WT and LGR5 KO organoids. Nuclei were
counterstained using TO-PRO-3 (blue). Arrows are included for image reference. E, quantification of -catenin. Error bars are S.D. (n 15–20 crypts). ***, p
0.001 versusWT.
Figure 2. LGR5 overexpression in CHO cells led to increase in cortical F-actin and cell–cell adhesion. A, representative confocal images of ICC showing
detection of LGR5 on the cell membrane at 4 °C in CHO-LGR5 stable cell line but not in parental CHO cells (panels a and b), phase-contrast images depicting
morphological changes resulting from LGR5 overexpression (panels c and d), and confocal images of F-actin stainingwith rhodamine-phalloidin (panels e and
f). B and C, quantification of cell length (B) and cortical actin (C) of CHO and CHO-LGR5 cells. Error bars are S.D. (n 20–30 cells). ***, p 0.001 versus parental
CHOcells.D, woundhealing assay results of CHOandCHO-LGR5 cells at 8 and 12hpostwounding. Error bars are S.E. (n 3). *, p 0.05 versus control CHOcells.
E, results of cell–cell adhesion analysis using the calcein-AM assay. Error bars are S.E. (n 3). **, p 0.01 versus CHO cells.
LGR5 regulation of cell–cell adhesion
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actin cytoskeleton and cell adhesion. F-actin staining showed
that cells overexpressing LGR5 displayed a more compact
structure and increased levels of F-actin at cell–cell contacts
(Fig. 3A), which were confirmed by quantification (Fig. 3B).
Cells expressing LGR5-C, however, displayed cytoneme-like
structures without increased levels of F-actin at the cell–cell
contacts (Fig. 3,A andB), consistent with the findings of Snyder
et al. (32). F-actin and G-actin were then extracted from the
three cell lines, and their relative levels were determined by
immunoblot analysis and quantified (Fig. 3, C and D). Cells
overexpressing LGR5-WT showed a higher ratio of F- to G-ac-
tin when compared with vector and LGR5-C cells. Of note,
HEK293 cells express RSPOs at very low levels as shown by
RT-quantitative PCR (17) and are highly sensitive to RSPO
stimulation inWnt/-catenin signaling (5, 6, 8), suggesting that
LGR5-induced actin cytoskeleton changes are RSPO-indepen-
dent. Indeed, treatment with RSPO1 overnight had no signifi-
cant effect on the F- to G-actin ratio either in control or LGR5
cells (Fig. 3, E and F), confirming that the activity is RSPO-inde-
pendent. Overall, these effects of LGR5 on F-actin structure
and cell adhesion in CHO and HEK293 cells are similar to the
phenotypes observedwith overexpression of LGR5 in colon and
liver cancer cell lines (15, 16). Importantly, the effects of LGR5
on the actin cytoskeleton were all displayed in the absence of
RSPO stimulation (either endogenous or exogenous), indicat-
ing that these activities do not involve the two E3 ligases RNF43
and ZNRF3.
LGR5 is not coupled to heterotrimeric G proteins
Next, we attempted to identify the intracellular mechanism
that mediates the effect of LGR5 on the actin cytoskeleton and
cell adhesion. Previously, we and others showed that LGR5 is
not coupled to any of the three types of heterotrimeric G pro-
teins that give rise to secondarymessenger formation (cAMPor
Ca2) or to-arrestin in response to RSPO stimulation (5, 6, 8).
Intriguingly, Kwon et al. (19) reported that LGR5 coupled to the
G12/13–Rho GTPase pathway to activate the serum response
factor response element pathway in the absence of RSPO stim-
ulation. However, neither binding nor direct activation of
G12/13 (exchange of GDP for GTP) by LGR5 was demon-
strated (19). As the G12/13 pathway plays a critical role in the
control of actin dynamics and cell migration, we examined
whether LGR5 activates G12/13 or any of the other heterotri-
meric G protein subclasses using a directmethod. Activation of
heterotrimeric G proteins by 7TM receptors can be monitored
directly by highly sensitive assays based on changes in biolumi-
nescence resonance energy transfer (BRET; Fig. 4A) that are
dependent on the release of theG subunit from the activated
GPCR and its subsequent binding to a fragment of GRK3 (33–
35). Using this assay, we tested whether LGR5 increases gua-
nine nucleotide exchange factor (GEF) activity of any of the four
major subtypes of heterotrimeric G proteins (Gs, Gi/o, Gq,
and G12/13) with RSPO stimulation. No significant signal by
LGR5 was detected with any of the four G proteins that were
tested (Fig. 4, B–E), whereas all positive control receptors
showed robust activity (Fig. 4, B–E). We then performed a
GTPase pulldown assay to measure activation of RhoA (which
occurs downstream of G12/13) in HEK293 cell lines stably
overexpressing vector, LGR5, orGPR56, aGPCRknown to acti-
vate the G12/13/RhoA signaling pathway constitutively (36).
Our results showed that GPR56 increased active RhoA levels
with or without serum stimulation compared with vector cells,
whereas LGR5 caused a slight decrease (not significant) in the
level of Rho-GTP (Fig. 4, F and G). Based on these results, we
conclude that LGR5 does not appear to bind to or function
through G12/13 and further confirmed that LGR5 is not cou-
pled to the other three subclasses of heterotrimeric G proteins.
LGR5 interacts with IQGAP1
LGR4 was found to interact with the intracellular scaffold
protein IQGAP1 to potentiate Wnt signaling, and it regulates
focal adhesion formation and cell migration (11). IQGAP1
plays a major role in the control of the actin cytoskeleton and
cell adhesion and migration, largely through modulation of the
Figure 3. Overexpression of LGR5 in HEK293T cells increased cortical
F-actin levels. A, confocal images of phalloidin staining of HEK293T cells
expressing vector control, Myc-tagged LGR5-WT, or LGR5-C. B, quantifica-
tion of fluorescence of the lines drawn in A. C, representativeWB results of G-
and F-actin as separated by the Triton X-100 method. D, quantification of
F- and G-actin WB results expressed as the ratio of F- versus G-actin. E, repre-
sentative WB results of G- and F-actin of HEK293-vector or -LGR5-WT cells
after treatmentwith RSPO1 (100ng/ml) or vehicle overnight. F, quantification
of WB results of G/F-actin. All error bars are S.E. (n 3). *, p 0.05 compared
with vector (Vect) cells. A.U., arbitrary units; CTL, control.
LGR5 regulation of cell–cell adhesion
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small G protein Rac1 and CDC42 (37, 38). Given the homology
of LGR4 and LGR5 and that IQGAP1 and IQGAP3 appeared as
proteins that co-purified with both receptors in mass spec-
trometry analysis (6), we tested whether LGR5 also interacts
with IQGAP1. Using recombinant overexpression and co-IP
analysis in HEK293T cells, we found that FLAG-IQGAP1 did
interact with Myc-tagged LGR5-WT as well as with the C-ter-
minal tail-truncated mutant LGR5-C (31) (Fig. 5A). As a neg-
ative control, we show that IQGAP1 was not pulled down with
Myc-tagged LGR5-ECD anchored to the membrane with a sin-
gle transmembrane domain (Fig. 5A). These results indicate
that IQGAP1 binds to the 7TMdomain of LGR5, and this inter-
action does not require the C-terminal tail (AA 837–907). To
verify that this interaction is not due to overexpression, co-IP
analysis was carried out with the LoVo colon cancer cell line,
which has high endogenous levels of LGR5 (39). Indeed, endog-
enous IQGAP1 in LoVo cells was pulled down using an LGR5-
specific antibody (Fig. 5B). To map the IQGAP1 domains that
interactwith LGR5,we utilized a series of FLAG-IQGAP1 trun-
cation and deletion mutants (Fig. 5C). Co-IP studies demon-
strated that LGR5 binds to the C-terminal half of IQGAP1
spanning amino acids 893–1657 (Fig. 5, C–E). Unlike LGR4
(11), however, we detected weak binding of LGR5 to the GRD
domain but strong binding to a variant lacking theGRDdomain
(GRD) (Fig. 5, D and E). We then tested whether LGR5 could
bind to a purified IQGAP1 fragment spanning amino acids
877–1558 (DR6 or GRDD1-RGCT) that was expressed in Esch-
erichia coli, purified, and shown to bind to CDC42 (26). LGR5-
WT, but not LGR5-ECD, pulled down DR6 (Fig. 5F). Overall,
these results suggest that the 7TM domain of LGR5 interacts
with the C-terminal portion of IQGAP1, although the exact
motifs from each partner have yet to be mapped.
LGR5 decreases phosphorylation of IQGAP1 to enhance
IQGAP1–Rac1 interaction
IQGAP1 regulates the actin cytoskeleton by functioning as
an effector of CDC42 or Rac1 (37). We examined whether
LGR5 affects the binding of IQGAP1 to CDC42, Rac1, or both.
Using co-IP analysis, we found that Rac1, but not CDC42 or
RhoA, was pulled downwith IQGAP1 in CHO-LGR5 cells (Fig.
6, A and B). In contrast, we did not detect any of the Rho
GTPases in association with IQGAP1 in control CHO cells
under the same conditions (Fig. 6,A and B). Furthermore, actin
consistently co-precipitated with IQGAP1 in CHO-LGR5 cells
but was not detectable in parental CHO cells (Fig. 6A).We then
tested whether the levels of total “free” active Rac1 (i.e. not
bound to IQGAP1) were altered due to LGR5 overexpression
using a GST-PBD (PAK1) pulldown assay. Of note, IQGAP1
binds active GTPases with higher affinity and different speci-
ficity than PAK1 PBD (40). The PBD-bound active Rac1 levels
were equivalent for each cell line (Fig. 6C), suggesting that
LGR5 may stabilize the binding of Rac1 to IQGAP1 without
affecting the overall levels of free active Rac1. In addition,
LGR5-mediated binding of Rac1/actin to IQGAP1 was not
affected by RSPO treatment (supplemental Fig. S2A), again
suggesting that the effect of LGR5 on the actin cytoskeleton is
independent of RSPO stimulation.
Binding of Rac1/CDC42 to IQGAP1 is regulated by phos-
phorylation of IQGAP1 at two sites (Ser-1441 and -1443) (25,
26, 41). Detailed kinetic analysis showed that phosphorylation
at Ser-1443 led to a decrease in the affinity of human IQGAP1
for Rac1 and CDC42 (27). To test whether LGR5 regulates
IQGAP1–Rac1 interaction through modulation of IQGAP1
phosphorylation,we probed the level of phospho-IQGAP1with
an anti-phosphoserine antibody (no antibody specifically
Figure 4. LGR5 did not exhibit GEF activity with any of the four hetero-
trimeric G protein subfamilies. A, a schematic diagram showing the princi-
ple of the BRET assay system. Agonist-bound GPCR exerts GEF activity, lead-
ing to the dissociation of inactive heterotrimeric G proteins into active
GTP-bound G and Venus-G subunits. The free Venus-G then interacts
with masGRK3ct-Nluc to produce the BRET signal. B–E, real-time measure-
ment of GEF activity in living cells. HEK293T/17 cells were transfected with
GPCR (dopamine D2 (D2R), M3 acetylcholine (M3R), dopamine D1 (D1R), or
bradykinin B2 receptor (BDKRB2), or LGR5) andG subunit (GoA, Gq, Gs, or
G13) with the BRET sensor pair Venus-G and masGRK3ct-Nluc. Agonists
(100 nM dopamine for dopamine D1 and D2 receptors, 100 nM acetylcholine
for M3 acetylcholine receptor, 100 nM bradykinin for bradykinin B2 receptor,
and 20 nM RSPO3 for LGR4 and LGR5) were applied on transfected cells to
stimulate GPCRs at 0 s. F, representative WB results of active RhoA GTPase
pulldown assay in stable HEK293T cells overexpressing vector, Myc-LGR5, or
Myc-GPR56. Cells were starved overnight and then treated 10% serum
for15min.G, quantificationofWB results of RhoGTPase.Error barsareS.E. (n
2). *, p 0.05 compared with vector and LGR5 cells.
LGR5 regulation of cell–cell adhesion
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against Ser-1441 or Ser-1443 of IQGAP1 is available (42)).
Overexpression of LGR5-WT in HEK293 cells led to a drastic
decrease in the level of phospho-Ser (Ser(P)) of IQGAP1 when
compared with vector cells (Fig. 6D). Remarkably, LGR5-C,
which does not increase cortical F-actin, did not alter the levels
of Ser(P) of IQGAP1 (Fig. 6D). Follow-up co-IP analysis con-
firmed that IQGAP1 showed increased binding to actin and
Rac1 in HEK293 cells (Fig. 6E). To examine whether the
decreased level of Ser(P) of IQGAP1 in LGR5 cells is due to
inhibition of phosphorylation or enhancement of dephosphor-
ylation, LGR5 and vector cells were treated with PMA for 10
min, which induces IQGAP1 phosphorylation at Ser-1441/
1443, and the Ser(P) levels of IQGAP1 were compared. As
shown in Fig. 6F, no difference was seen between LGR5 and
vector in response to PMA treatment, suggesting that LGR5
did not inhibit acute phosphorylation of IQGAP1 by PKC.
To confirm that the detected phospho-IQGAP1 signal was
specific for Ser-1441/1443 phosphorylation, we generated an
IQGAP1 mutant with both serines changed to alanine (SKS3
AKA). As shown by IP in supplemental Fig. S2B, no signal was
detected with the mutant IQGAP1, whereas IQGAP1-WT
showed a strong signal following PMA treatment. These results
suggest that the LGR5-induced decrease in IQGAP1 phosphor-
ylation at Ser-1441/1443 was probably due to increased
dephosphorylation.
Knockdown of LGR5 in colon cancer cells leads to loss of
IQGAP1-associated Rac1/actin and disruption of cytoskeletal
structure
The LoVo colon cancer cell line is mutated in the tumor
suppressor andWnt inhibitor APC and expresses high levels of
LGR5 and IQGAP1 (39). Microarray data of this cell line in the
Cancer Cell Line Encyclopedia showed no expression of RSPOs
(43), which we confirmed by RT-quantitative PCR analysis.
LoVo cell lines stably expressing two independent LGR5
shRNAconstructs, shLGR5-86 and shLGR5-89, alongwith vec-
tor control were generated. Both shRNA constructs yielded a
90% reduction in LGR5 as verified by WB and ICC (Fig. 7, A
andB, top panel). A LoVo cell line stably expressing an IQGAP1
shRNA (shIQGAP1-85), which we used previously in lung can-
cer cell lines (11), was also generated, and loss of IQGAP1 was
confirmed by WB (Fig. 7A).
We first examined F-actin structures in these cell lines and
found that, strikingly, shIQGAP1, shLGR5-86, and shLGR5-89
cell lines all displayed a significant loss of cortical F-actin and
showed an overall disorganized cytoskeletal structure when
compared with control cell lines (Fig. 7B, lower panels). Corre-
spondingly, loss of LGR5 expression resulted in reduced levels
of IQGAP1 localized to the plasma membrane at cell–cell
adhesion sites (Fig. 7, C and D). Using ICC, we also analyzed
Figure 5. LGR5 binds to the C-terminal half of IQGAP1. A, WB results of FLAG-tagged IQGAP1 co-IP with Myc-LGR5-WT, Myc-LGR5-C, and membrane-
tetheredMyc-LGR5-ECD.B,WB results of co-IPof endogenous IQGAP1andLGR5 inLoVocells.C, a schematicdiagramof IQGAP1domain structure and theLGR5
binding results of variousmutants tested. The domains are as follows:CHD, calponin homology domain; IR, IQGAP-specific repeatmotif;WW, domainwith two
conserved Trp (W) residues; IQ, calmodulin-binding IQ motif; RGCT, RasGAP C terminus; NT, N terminus; CT, C terminus. The numbers denote the amino acid
residues where mutant proteins/deletion regions start and end. D, WB results of co-IP of FLAG-IQGAP1mutants with LGR5-WT using whole-cell lysates. E, WB
results of co-IP of FLAG-IQGAP1 C-terminal tail mutants with Myc-LGR5-WT using whole-cell lysates. F, WB results of co-IP of purified IQGAP1 fragment (DR6;
amino acids 877–1558) with LGR5-WT. NS, indicates nonspecific band. Each experiment was repeated two to three times, and shown here are representative
WB results.
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E-cadherin and -catenin, which are critical to the formation
and stabilization of cell–cell adhesion (24). Loss of LGR5
or IQGAP1 resulted in decreased membrane-associated -
catenin accompanied by increased -catenin levels in the cyto-
plasm (Fig. 7, E and F), which were also confirmed byWB (Fig.
7A, lower panel). However, we did not observe any obvious
changes in the level of E-cadherin or its localization (supple-
mental Fig. S3). These results suggest that LGR5–IQGAP1
functions to regulate -catenin localization and is essential for
the formation and/or stabilization of cortical F-actin.
Formation of stable E-cadherin–mediated cell–cell adhesion
depends on cortical F-actin, which is connected to the adhesion
complex via-catenin (44). The loss of cortical F-actin in LGR5
and IQGAP1 KD cells suggests that loss of LGR5–IQGAP1
interaction may decrease cell–cell adhesion. Using the cal-
cein-AM fluorescence-based cell–cell adhesion assay, we dem-
onstrated that KD of LGR5 resulted in a reduction in cell–cell
adhesion (Fig. 8A). Cells with poorly organized cortical F-actin
are also expected to have increased levels of soluble E-cadherin
(45). Indeed, we found that LoVo cells lacking LGR5 showed a
significant increase in the ratio of soluble versus insoluble
E-cadherin when extracted by Nonidet P-40 (Fig. 8, B and C).
As overexpression of LGR5-WT led to a decrease in phos-
phorylation of Ser-1441/1443 of IQGAP1 and consequently
increased Rac1 binding to IQGAP1, we tested whether the
opposite was true in LoVo cells with KD of LGR5. Co-IP was
performed with an anti-IQGAP1 antibody to pull down endog-
enous IQGAP1 in parental, vector, and shLGR5-89 cells (shIQ-
GAP1 cells were included as a negative control for IQGAP1
antibody specificity) (Fig. 8D). As expected, we found that KD
of LGR5 resulted in loss of Rac1 and actin association with
IQGAP1(Fig.8D).Furthermore, the levelof IQGAP1phosphor-
ylation was found to be higher in LGR5 KD cells (Fig. 8E).
Together with the LGR5 overexpression data, these findings
coherently suggest a mechanism whereby LGR5 reduces phos-
phorylation of IQGAP1 at Ser-1441/1443 to increase the
IQGAP1–Rac1 interaction and ultimately enhance cell–cell
adhesion via regulating the actin cytoskeleton.
Discussion
LGR5 is currently the most widely recognized and utilized
stem cell marker in the gastrointestinal tract and several other
epithelial tissues, and it is up-regulated in a substantial fraction
of solid tumors (1, 2). However, the exact roles andmechanisms
of LGR5 in normal adult stem cells and cancer cells remain
poorly defined. Notably, expression of LGR5 is not essential for
the survival of crypt stem cells in vivo or ex vivo (6, 28). The
function of LGR5 in cancer cells appeared to be tumor-type
dependent with tumor suppressor-like activity in colon and
liver cancer cells and tumor-promoting activity in other cancer
cell types (15, 16, 46). Mechanistically, multiple studies showed
that LGR5 can bind the RSPO1–4 family of stem cell factors to
potentiate Wnt/-catenin signaling in HEK293T cells (5, 6, 8).
RSPOs (with the exception of RSPO4) also bind to the two E3
ligases RNF43 and ZNFR3, which ubiquitinate Wnt receptors
for degradation, and the co-crystal structure of LGR5–RNF43–
RSPO has been solved (47, 48). Based on these studies, the cur-
rent model is that LGR5, like LGR4, functions as a high-affinity
Figure 6. LGR5 increased binding of Rac1 to IQGAP1 via regulating phosphorylation of IQGAP1 at Ser-1441/1443. A, WB results of IQGAP1, Rac1, and
actin following IP of IQGAP1 in parental CHO (P) andCHO-LGR5 cells.HC and LC, heavy and light chains of the IP antibody, respectively. B, WB results of IQGAP1,
Rho, andCDC42 following IP of IQGAP1.C, WB of active (GTP-bound; binding to PAK1-PBD) and total Rac1.D, WB results of Ser(P) of IQGAP1 (pSer (IQ1)) probed
by anti-phosphoserine antibody following IP of IQGAP1 in HEK293 cells overexpressing LGR5 or LGR5-C (lacking C-terminal tail). E, WB results of Ser(P), LGR5,
actin, and Rac1 following IP of IQGAP1. F, WB results of Ser(P) of IQGAP1 in HEK293-vector (V) or -LGR5 cells before and after treatment with PMA. Each
experiment was repeated two to three times, and shown here are representative WB results.
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co-receptor of RSPOs, facilitating the binding of RSPOs to
inhibit RNF3/ZNRF3, leading to enhanced Wnt signaling (49).
However, direct evidence of RSPO–LGR5 mediating the inhi-
bition of RNF43/ZNRF3 has never been reported. Further-
more, KO of LGR5 in multiple tissues led to increased levels of
Axin2 (marker of Wnt/-catenin signaling), suggesting that
LGR5 does not play a major, positive role in Wnt/-catenin
signaling in stem cells in vivo (12–14). Remarkably, a consistent
finding is that LGR5 overexpression in cancer cells alters the
actin cytoskeleton structure and increases cell–cell adhesion in
the absence of endogenous or exogenousRSPOstimulation (15,
16). Such LGR5-induced changes in the actin cytoskeleton are
unlikely to bemediated by inhibition of RNF43/ZNRF3 because
these changes occur in the absence of RSPOs, which are essen-
tial for interacting with RNF43/ZNRF3. Here, we present evi-
dence for a novel mechanism whereby LGR5 is coupled to the
intracellular scaffold signaling protein IQGAP1 to regulate the
actin cytoskeleton and cell–cell adhesion.
IQGAP1 interacts with a plethora of receptors and effectors
to coordinate signaling and regulate actin cytoskeleton dynam-
ics. We found that LGR4 interacts with the GRD domain of
IQGAP1 to potentiate both the canonical and non-canonical
pathways ofWnt signaling (11). In comparison, LGR5 interacts
not only with the GRD domain but also with a C-terminal
domain of IQGAP1. Interestingly, overexpression of LGR4 and
LGR5 has an opposite effect on the actin cytoskeleton and cell
adhesion and migration (11, 15, 16, 50, 51). The distinctive
domains of IQGAP1 involved in binding to LGR5may underlie
the differential effect of LGR4 and LGR5 on these cellular pro-
cesses and morphology. The 7TM domains between LGR4 and
LGR5 are highly conserved, whereas their C-terminal tails are
quite divergent. LGR5 lacking its C-terminal tail is endocytosis-
Figure 7. KD of LGR5 in LoVo colon cancer cells altered cytoskeletal structure and decreased the level of membrane-associated IQGAP1 and
-catenin.A,WB results in control and LoVo cellswith KDof IQGAP1or LGR5. B, confocal images of LGR5 (green) in control and cellswith KDof IQGAP1or LGR5.
F-actin was stained with rhodamine-labeled phalloidin (red). C, confocal images of IQGAP1 in control and LoVo cells with KD of LGR5 or IQGAP1. D, quantifi-
cation of membrane-associated IQGAP1. Error bars are S.E. (n 20–30 cells). ***, p 0.001 versus parental and vector cells. E, confocal images of -catenin. F,
quantification of cytoplasmic -catenin based on relative signal intensity. Error bars are S.E. (n  20–30 cells). ** and ***, p  0.01 and 0.001, respectively,
compared with parental and vector cells. Images in C and E are 2.5	magnification compared with B. cyto-cat, cytoplasmic -catenin; t-cat, total -catenin.
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impaired, potentiates Wnt/-catenin signaling (31, 52), and
induces the formation of cytonemes inHEK293 similar to those
induced by full-length LGR4 (32). These findings imply that the
C-terminal tail of LGR5, although not essential for IQGAP1
binding, may interact with additional domains on IQGAP1 or
other proteins bound to IQGAP1 to exert effects distinct from
those of LGR4. As LGR5 does not appear to affect acute phos-
phorylation of IQGAP1, a potential mechanism is that the
C-terminal tail of LGR5 recruits a Ser/Thr phosphatase to de-
phosphorylate IQGAP1.
Initially, we found that overexpression of LGR5 consistently
led to increased binding of Rac1 and actin to IQGAP1 in co-IP
analysis. Because it was reported that binding of Rac1/CDC42
to IQGAP1 is inhibited by phosphorylation at Ser-1441/1443 of
IQGAP1 (26, 27, 41), we asked whether LGR5modulates phos-
phorylation of IQGAP1 at these sites to regulate IQGAP1–Rac1
interaction. Indeed, LGR5 overexpression and KD of LGR5 led
to a significant decrease and increase in Ser-1441/1443 phos-
phorylation, respectively, and LGR5 had no effect on PMA-
induced phosphorylation of IQGAP1. Furthermore, overex-
pression of LGR5-C, which induced cytoneme formation
without an increase in total F-actin, had no effect on phosphor-
ylation (Fig. 5D). These results suggest that the C-terminal tail
of LGR5 regulates phosphorylation of the two serine sites,
potentially through recruitment of phosphatase(s). In turn,
decreased levels of phosphorylated IQGAP1 at Ser-1441/1443
led to increased Rac1 binding to IQGAP1. Importantly, Rac1-
bound IQGAP1 can no longer interact with -catenin but can
still bind to and cross-link F-actin filaments (20), leading to an
increase in E-cadherin–-catenin–-catenin complex forma-
tion and F-actin cross-linking and therefore stronger cell–cell
adhesion (20, 24). Thus, we propose a model whereby LGR5-
induced depletion of IQGAP1 phosphorylation increases
IQGAP1–Rac1 interaction with concomitant loss of IQGAP1–
-catenin interaction, eventually leading to strengthening of
cell–cell adhesion (Fig. 9). Furthermore, the slight increase of
Wnt/-catenin signaling in LGR5 KO tissues (12–14) may be
explained by release of -catenin from adherens junction sites
at the plasmamembrane in LGR5KO cells withweakened cell–
cell adhesion (53).
The critical role of LGR5 in the control of cell–cell adhesion
may also shed light on reasons why LGR5 is specifically
expressed by adult stem cells in various epithelial tissues. Stem
cell niches provide an adhesivemilieu that can selectively retain
daughter stem cells but not differentiated daughter cells (54). In
the small intestine, LGR5 stem cells (14 cells per crypt) are
interspersed with Paneth cells throughout the base of the crypt
or stem cell niche (55). In vivo imaging has shown that LGR5
Figure 8. KD of LGR5 in LoVo cells resulted in loss of IQGAP1 interaction with Rac1/actin and decreased cell–cell adhesion. A, results of calcein-AM
cell–cell adhesion assay. Error bars are S.E. (n 3). *, p 0.05 and **, p 0.01 versus controls. B, representativeWB analysis results of soluble (S) and insoluble
(I) E-cadherin in LoVo cells with vector control, KD of LGR5 (shLGR5-89), or KD of IQGAP1 (shIQ1) when extracted with the indicated concentrations of Nonidet
P-40 (NP40). C, quantification of WB results of E-cadherin. Error bars are S.E. (n 3). *, p 0.05 compared with vector cells. D, WB results of IQGAP1, actin, and
Rac1 in control and LoVo cells with KD of LGR5 or IQGAP1. E, WB of serine phosphorylation of IQGAP1 in LGR5 KD LoVo cells.
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stem cells located at the crypt base experience a survival advan-
tage over border stem cells that can be passively displaced into
the transit-amplifying region along the sides of the crypt (56). It
is thus tempting to speculate that the stemcells that form stron-
ger cell–cell adhesion contacts have a competitive advantage in
terms of being retained in the niche and remaining as stemcells.
Given that LGR5 is not essential for the growth and survival of
crypt stem cells, it is conceivable that the receptor may primar-
ily function to promote strong cell–cell adhesion in stem cells,
which in turn retains these cells within the crypt base to main-
tain homeostasis in the intestinal epithelium. Indeed, a recent
study showed that intestinal stem cells expressing LGR5 with-
out its C-terminal tail were less “fit” in vivo as manifested by
their decreased lifespan in the intestine (18) This is consistent
with our model that LGR5 lacking the C-terminal tail cannot
reduce phosphorylation of IQGAP1, leading to a lower level of
Rac1 binding and a decrease in cell–cell adhesion and thus
faster elimination in vivo.
Experimental procedures
Plasmids and cloning
Plasmids encoding Myc-LGR5, Myc-LGR5-ECDTM, Myc-
LGR5-C, and all FLAG-taggedmouse IQGAP1deletion/trun-
cation mutants were generated as described previously (5, 11).
Myc-tagged full-length human GPR56 was cloned into pIRES-
puro3 using standard PCR-based methods. FLAG-tagged
mouse IQGAP1-CT truncation mutant was constructed by
amplifying the fragment containing AA 962–1657 frommouse
IQGAP1 pCMV-sport6 (Addgene). The PCR product was sub-
cloned into a pcDNA3.1 vector modified to incorporate an
N-terminal FLAG tag. GST-PBD (PAK1) was a gift from Dr.
Jeffrey Frost (University of Texas Health Science Center-Hous-
ton). The heterotrimeric G protein activation plasmids were
described previously (33).
Recombinant proteins, antibodies, and chemicals
Recombinant human RSPO1 was purchased from R&D Sys-
tems. IQGAP1 DR6 recombinant protein was produced and
purified from E. coli as reported previously (26). For crypt
organoid cultures, Noggin was purchased from Peprotech;
N-acetylcysteine was from Sigma; andN2, B27, andmouse EGF
were all purchased from Life Technologies. All commercial
antibodies were used in accordance with the manufacturers’
guidelines. For Western blot analysis, anti-LGR5 (Abcam
ab75732), anti-Rac1 (BD Biosciences catalog number 610650),
anti-IQGAP1 (BD Biosciences catalog number 610611), anti-
FLAG (Sigma catalog number F7425), anti-G13 (Santa Cruz
Biotechnology sc-410), andCell Signaling Technology antibod-
ies anti-CDC42 (catalog number 2466), anti-Rho (catalog num-
ber 8789), anti-Myc (catalog number 2272 or 2278), anti--
catenin (catalog number 9562), anti-E-cadherin (catalog
number 3195), anti-phospho-Ser PKC substrate antibody (cat-
alog number 2261), and anti--actin (catalog number 4970)
were used. Specificities of all antibodies were confirmed based
on protein size and correlation with recombinant expression.
For ICC experiments, anti--catenin-Alexa Fluor 488 (Cell Sig-
naling Technology catalog number 2849), anti-E-cadherin-Al-
exa Fluor 488 (Cell Signaling Technology catalog number
3199), anti-IQGAP1 (Bethyl Laboratories catalog number
A301), anti-LGR5 (BD Biosciences catalog number 562731),
and anti-Myc-Cy3 (Sigma catalog number C6594) were used.
TO-PRO-3, rhodamine-phalloidin, and rabbit anti-rat Alexa
Fluor 488, and goat anti-rabbit Alexa Fluor 488 secondary anti-
bodies were purchased from Life Technologies.
Cell culture and shRNA stable cell line generation
HEK293T and CHO-K1 cells were purchased from ATCC.
HEK293T and CHO-K1 cells were cultured in high-glucose
DMEM and F-12/Ham’s medium, respectively, and supple-
Figure 9. A schematic diagram illustrating themechanism of LGR5 in the regulation of cell–cell adhesion through the IQGAP1–Rac1 pathway. In the
absence of LGR5 (left panel), phosphorylated IQGAP1 (IQ1) is free of Rac1-GTP and can thus bind to -catenin () to disrupt the interaction of -catenin and
-catenin (), leading to separation of the E-cadherin (E-cad) adhesion complex from the actin cytoskeleton and weak cell–cell adhesion. In the presence of
LGR5 (right panel), the receptor reduces phosphorylation of IQGAP1, which then binds Rac1-GTP, leading to loss of binding to -catenin as well as enhanced
cross-linking of F-actin. This results in the linkage of E-cadherin adhesion complex to the cytoskeleton and stronger cell–cell adhesion.
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mentedwith 10% fetal bovine serum (FBS) and penicillin/strep-
tomycin (pen/strep) at 37 °C with 95% humidity and 5% CO2.
CHO-LGR5 cells were purchased from DiscoveRx and main-
tained in F-12/Ham’s medium supplemented with 10% FBS,
300 g/ml hygromycin, 800 g/ml geneticin, and pen/strep.
LoVo cells were obtained from the laboratory of Dr. Shao-Cong
Sun atM. D. AndersonCancer Center, Houston,TX, andmain-
tained in RPMI 1640 medium with 10% FBS and pen/strep. To
generate stable KD of LGR5 or IQGAP1, LoVo cells were
infected with lentivirus particles produced by co-transfecting
HEK293T cells with a pLKO.1 vector incorporating either the
LGR5- or IQGAP1-targeted shRNA and packaging plasmids
psPAX2 and pMD2.G using FuGENE 6 (Roche Applied Sci-
ence). Virus-infected cells were selected with puromycin. The
shRNA clones were from GE Dharmacon with clone numbers
as follows: human LGR5, TRCN0000011586 (shLGR5-86),
human LGR5, TRCN0000011589 (shLGR5-89), and human
IQGAP1, TRCN0000047485 (shIQGAP1-85). The corre-
sponding sequences can be accessed on the GE Dharmacon
website.
Intestinal crypt organoid culture
All animal experimentswere performed in accordancewith a
protocol approved by the Animal Protocol Review Committee
of the University of Texas Health Science Center at Houston.
B6.129P2-LGR5tm1(cre/ERT2)Cle/J mice were purchased from
The Jackson Laboratory and bred to produce wild-type and
LGR5 KO mutant offspring. Because LGR5 KOs are perinatal
lethal, pups were sacrificed, and intestines were collected
immediately after birth. Tail genotyping was conducted follow-
ing the standard PCR protocol provided by The Jackson Labo-
ratory. Mouse intestinal crypt organoid cultures were estab-
lished as published previously (29). Briefly, small intestines
were harvested and washed to remove contaminants and villi.
Intestinal fragments were incubated in EDTA for 30 min,
strained, and pelleted. Crypts were resuspended in Matrigel
with DMEM/F-12 containing 10 mM HEPES, GlutaMAX, 1	
B27, 1	N2, 1 mM N-acetylcysteine, 50 ng/ml mouse EGF, 100
ng/ml mouse Noggin, 20 ng/ml RSPO1, and pen/strep. The
medium was replenished every 2–3 days, and the crypt
organoids were mechanically broken down with a glass pipette
and passaged every 5–6 days.
RT-PCR
Total RNAwas extracted by lysing the cells with TRIzol (Life
Technologies) followed by the successive addition of chloro-
form and isopropanol for phase separation and RNA precipita-
tion, respectively. Samples were run through RNeasy Mini kit
columns (Qiagen) according to the manufacturer’s protocol,
eluted with RNase-free water, and DNase-treated. cDNA was
produced using the iScript kit (Bio-Rad).
Western blotting and immunoprecipitation
Heterotrimeric G protein BRET assays were performed as
described before (35). Rho-GTP pulldown was carried out
using an assay kit (Cytoskeleton, Inc. catalog number BK036).
F-actin and G-actin were separated and extracted using the
Triton X-100 assay essential as described previously (57).
Quantification of soluble versus insoluble E-cadherin was per-
formed as described before (45). For WB, cells were lysed with
radioimmune precipitation assay buffer (50mMTris-Cl, pH7.4,
150 mMNaCl, 1 mMDTT, 1% Triton X-100, 1% sodium deoxy-
cholate, 0.1% SDS) or GTPase Buffer (25 mM Tris, pH 7.5, 30
mM MgCl2, 0.13 M NaCl, 0.5% Nonidet P-40) for experiments
involving GTPase activity. Both buffers were supplemented
with protease and phosphatase inhibitors. HRP-labeled sec-
ondary antibodies (Cell Signaling Technology) were utilized for
detection along with the standard ECL protocol. For co-immu-
noprecipitation experiments, cell lysates were incubated3–4
h at 4 °C with anti-Myc magnetic beads (Cell Signaling Tech-
nology), anti-FLAG magnetic beads (Sigma), glutathione mag-
netic beads (Sigma), or primary antibody and protein A/G-aga-
rose beads (Santa Cruz Biotechnology). Precipitates were
washed with lysis buffer followed by PBS and boiled with 2	
SDS sample buffer prior to loading for SDS-PAGE andWestern
blot analysis. G protein BRET assays were carried out as
described previously (33). All ligand treatments were per-
formed with Wnt3a-conditioned medium (diluted 1:5) and 30
ng/ml RSPOunless otherwise stated. All experiments were per-
formed at least three times.
Immunocytochemistry and confocal microscopy
For ICC, CHO and LoVo cell lines were reseeded into 8-well
chamber slides (BD Biosciences) and allowed to adhere over-
night. Cells were then washed, fixed with 4% paraformaldehyde
for 15 min, and permeabilized with 0.1% saponin for 10 min.
Cells were incubated with the indicated antibodies for 1 h, rho-
damine-phalloidin for 20min, andTO-PRO-3nuclear counter-
stain for 5min. For ICC of intestinal crypt organoids, organoids
were collected, fixed for 30 min, and washed from residual
Matrigel. Permeabilization and staining were performed in
0.2-ml tubes. Organoids were mounted onto slides using
Vectashield (Vector Laboratories). Confocal microscopy
images were collected and analyzed using the Leica TSC SP5
system and LAS AF Lite software. All experiments were per-
formed at least three times.
Wound and cell–cell adhesion assays
For thewoundhealing assays, CHOorLoVo cellswere plated
in 12-well plates, grown to near confluence, and starved in
serum-free medium overnight. The next day cells were
scratched, and serum-free medium was replaced with 10%
serum. Wound closure was observed over a 12–20-h period,
and images were captured and quantified using ImageJ (58).
Cell–cell adhesion assays were performed by resuspending
CHOor LoVo cells in serum-freemediumand incubatedwith 5
M calcein-AM dye for 30 min at 37 °C. After incubation, non-
incorporated calcein-AM was removed by three washes with
serum-free medium. 1 	 104 calcein-AM-labeled cells were
added to a confluentmonolayer of CHOor LoVo cells grown in
a 96-well plate. After 1- (LoVo) or 2-h (CHO) incubation at
37 °C, non-adherent calcein-AM-labeled cells were removed by
washing with PBS. Relative fluorescence intensity of the adher-
ent calcein-AM-labeled cells was measured using a Tecan
M1000 plate reader with an excitation wavelength of 485 nm
and an emission wavelength of 530 nm. All experiments were
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performed at least three timeswith triplicates or quadruplicates
in each experiment. Data were analyzed using GraphPad Prism
software.
Quantification and statistical analyses
All quantifications of Western blots and confocal images
were performed using ImageJ (58) to measure integrated den-
sity or relative length (CHO cells). Cortical actin was quantified
by averaging the integrated density/pixel across a five-pixel
length (n  20 cells or crypts). For LoVo cells, IQGAP1 and
-catenin were quantified by measuring the integrated density
of membrane and cytoplasm, respectively (n 20–30 cells for
each cell line). For each organoid type, the number of cells with
wild-type junctional -catenin expression was counted for the
first 20 cells of each crypt starting at the base, averaged, and
presented as a percentage (n  15–20 crypts). Student’s t test
and analysis of variance were performed using GraphPad
Prism.
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